Novartis Moves Ahead With Drug to Treat Non-Hodgkin's lymphoma - Fox News
InPharmNovartis Moves Ahead With Drug to Treat Non-Hodgkin's lymphomaFox NewsKnown as MabThera in Europe, it is used to treat non-Hodgkin's lymphoma (NHL) and rheumatoid arthritis. The Swiss drugmaker's generics unit Sandoz started ...Sandoz initiates Phase II non-Hodgkin's lymphoma and rheumatoid arthritis trialTrading Markets (press release)Novartis challenges Roche with MabThera biosimilarInPharmSandoz Initiates Mid-stage Clinical Trial For Biosimilar Rituximab - UpdateRTT NewsThe Pharma Letterall 28 news articles��
Blog Content
Post a Comment